SAGE - Sage Therapeutics Inc. Profit before interest, taxes and amortization
Sage Therapeutics, Inc. (SAGE) generates revenue from the treatment of neurological disorders and postpartum depression via pharmacy chains. The absolute operating profit illustrates current cash flow dynamics, with the metric currently valued at . Growth is driven by robotic molecule discovery platforms and optimized chemical compound supplies, which eliminate clinical trial deadline disruptions.
sagerx.com (SAGE) - metric breakdowns and financial figures
- price and consensus price forecast:
- market capitalization statistics:
- book capitalization data:
- company total debt and liquidity indicators:
All Debt to Shareholders' Equity Ratio Sage Therapeutics, Inc.|SAGE - Long-Term Debt to Capital|Current Liabilities to Capital Sage Therapeutics Inc|SAGE - Company Debts|Debt to Net Assets Ratio Sage Therapeutics, Inc.|SAGE - Company Long-Term Debts|Company Short-Term Debts Sage Therapeutics|Critical Liquidity Ratio sagerx.com
- earnings and market ratios statistics:
SAGE - Net Profit|Expected Net Profit Sage Therapeutics, Inc.|SAGE - Price to Earnings Ratio|Forward P/E Multiple Sage Therapeutics, Inc|SAGE - Price/Earnings to Growth Multiple|Enterprise Value to Operating Income Before Depreciation Ratio Sage Therapeutics, Inc.|SAGE - Operating profit EBITDA|Net earnings per share for the last four quarters Sage Therapeutics|SAGE - Net earnings per share (EPS TTM)|Year-over-year net earnings per share growth for the last 12 months sagerx.com|SAGE - Earnings per share growth in current year|Consensus forecast of earnings per share growth for next year Sage Therapeutics, Inc.
- sales and revenue indicators:
Analysis of all company metrics:Sage Therapeutics, Inc.
The dynamics of operating income before taxes and depreciation reflect the commercialization efficiency of Sage Therapeutics, Inc. (SAGE) innovations within the CNS segment. This metric measures cash flow from core operations before accounting for amortization and financial obligations, allowing for an assessment of the actual scale of the business and the capitalization rate of Zurzuvae's success, confirming the company's market leadership provided its technological stack remains current.
Who Sage Therapeutics, Inc. competes with
Biogen Inc. (BIIB) - Profit before interest, taxes and amortization|NBIX - Profit before payment of interest, taxes and amortization|RGC (Regencell Bioscience Holdings Limited) - Operating profit before amortization|Axsome Corp (AXSM) - Profit before payment of interest, taxes and amortization|ACAD - Operating income before deduction of amortization|Operating profit before deduction of amortization XENE|VKTX - Operating profit before depreciation charges|Operating profit before deduction of amortization SUPN (supernus.com)|Operating income before deduction of amortization Catalyst Pharmaceuticals Inc|Denali Therapeutics Inc. - Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization HRMY|BHVN: Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization AMLX (Amylyx Pharmaceuticals)|Trevi Therapeutics, Inc. (TRVI) - Profit before payment of interest, taxes and amortization|Profit before interest, taxes and amortization Praxis Precision Medicines, Inc. (PRAX)|AVXL (anavex.com) - Operating profit EBITDA|Operating profit before amortization CBLL (CeriBell Corp)|Profit before payment of interest, taxes and amortization Prothena Biosciences (PRTA)|Operating income before deduction of amortization Alector|Operating profit EBITDA ANNX (annexonbio.com)|Income before deduction of interest, taxes and amortization OMER|NGNE: Operating profit before deduction of amortization|ACIU (AC Immune Corp) - Operating profit before amortization|VYGR: Operating profit EBITDA|Profit before interest, taxes and amortization Neumora Therapeutics, Inc. (NMRA)|SCLX (Scilex Holding) - Operating profit EBITDA|Operating profit before amortization TVGN (Tevogen Bio)|Operating profit EBITDA ACOG|CGTX - Profit before interest, taxes and amortization|Inhibikase Pharma - Operating profit before deduction of amortization|Operating income before deduction of amortization cassavasciences.com (SAVA)|Assertio Holdings - Operating profit EBITDA|Operating income before deduction of amortization Coya Therapeutics COYA|VTGN: Operating profit EBITDA|Operating profit before amortization OVID|Profit before payment of interest, taxes and amortization Acumen Pharmaceuticals|CRVO: Income before deduction of interest, taxes and amortization|Operating profit EBITDA ATHE|CLNN - Profit before interest, taxes and amortization|Profit before payment of interest, taxes and amortization PepGen Inc PEPG|Operating income before deduction of amortization jupiterneurosciences.com (JUNS)|Relmada Therapeutics, Inc. - Operating profit EBITDA|Income before deduction of interest, taxes and amortization ANVS (annovisbio.com)|Grace Tx (GRCE) - Profit before payment of interest, taxes and amortization|Firefly Neuroscience (AIFF) - Operating profit EBITDA|Profit before payment of interest, taxes and amortization Klotho Neurosciences Inc|neurosense-tx.com (NRSN) - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization Reviva Pharmaceuticals Holdings, Inc. (RVPH)|Operating profit EBITDA MetaVia, Inc. (MTVA)|NeurAxis, Inc - Operating profit before deduction of amortization|Operating profit EBITDA Helius Medical HSDT|PASG - Profit before payment of interest, taxes and amortization|Profit before interest, taxes and amortization Neuphoria Therapeutics, Inc.|Minerva Neurosciences Inc (NERV) - Profit before payment of interest, taxes and amortization|Athira Pharma, Inc. - Income before deduction of interest, taxes and amortization|ADXN (Addex) - Operating profit EBITDA|Alzamend Neuro, Inc. - Profit before deduction of interest, taxes, depreciation and amortization|Operating profit EBITDA CYCN|PTIX - Profit before interest, taxes and amortization|Profit before payment of interest, taxes and amortization pasitheaclinics.com KTTA|Income before deduction of interest, taxes and amortization CRGT|Avenue Therapeutics Inc - Operating profit EBITDA|Brainstorm Cell Therapeutics, Inc. (BCLI) - Operating profit before deduction of amortization|CARA: Operating profit EBITDA|Chromocell - Income before deduction of interest, taxes and amortization|ELYM (Eliem Therapeutics, Inc.) - Operating profit EBITDA|ITCI (intracellulartherapies.com) - Company profit before taxes, interest and amortization|Profit before payment of interest, taxes and amortization Longboard Pharma (LBPH)|Marinus - Operating profit before amortization|Operating profit EBITDA NKGN (nkgenbiotech.com)|NeuroBo Pharma - Profit before payment of interest, taxes and amortization|SNPX: Operating profit before deduction of amortization|Profit before interest, taxes and amortization Trevena|VIGL: Operating profit EBITDA|WENA - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization Cerevel
